Insider Transactions in Q2 2025 at Sight Sciences, Inc. (SGHT)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2025
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
27,900
+1.98%
|
$111,600
$4.22 P/Share
|
|
Jun 05
2025
|
Catherine Mazzacco |
BUY
Grant, award, or other acquisition
|
Direct |
30,952
+28.28%
|
-
|
|
Jun 05
2025
|
Brenda Jane Larsen Becker |
BUY
Grant, award, or other acquisition
|
Direct |
30,952
+28.14%
|
-
|
|
Jun 05
2025
|
Donald Zurbay |
BUY
Grant, award, or other acquisition
|
Direct |
30,952
+15.77%
|
-
|
|
Jun 05
2025
|
Tamara Fountain |
BUY
Grant, award, or other acquisition
|
Direct |
30,952
+27.55%
|
-
|
|
Jun 05
2025
|
Erica J. Rogers |
BUY
Grant, award, or other acquisition
|
Direct |
30,952
+15.0%
|
-
|
|
Jun 05
2025
|
Staffan Encrantz |
BUY
Grant, award, or other acquisition
|
Direct |
30,952
+2.24%
|
-
|
|
Jun 05
2025
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
40,951
+3.01%
|
$163,804
$4.24 P/Share
|
|
Jun 04
2025
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
21,674
+1.67%
|
$86,696
$4.17 P/Share
|
|
Jun 03
2025
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
25,230
+1.97%
|
$75,690
$3.97 P/Share
|
|
Jun 02
2025
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
30,799
+2.44%
|
$92,397
$3.88 P/Share
|
|
May 30
2025
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
42,753
+3.44%
|
$128,259
$3.67 P/Share
|
|
May 29
2025
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
60,128
+4.94%
|
$180,384
$3.59 P/Share
|
|
May 28
2025
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
26,715
+2.38%
|
$80,145
$3.52 P/Share
|
|
May 27
2025
|
Staffan Encrantz |
BUY
Open market or private purchase
|
Direct |
41,346
+3.72%
|
$124,038
$3.44 P/Share
|
|
May 19
2025
|
Alison Bauerlein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,066
-2.01%
|
$39,198
$3.48 P/Share
|
|
May 16
2025
|
Matthew Link Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,631
+0.79%
|
$19,893
$3.02 P/Share
|
|
May 16
2025
|
Manohar K. Raheja EVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
12,767
+7.07%
|
$38,301
$3.02 P/Share
|
|
May 12
2025
|
Gerhard F Burbach |
BUY
Grant, award, or other acquisition
|
Direct |
74,766
+44.1%
|
-
|
|
Apr 02
2025
|
Matthew Link Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,042
-0.6%
|
$10,084
$2.31 P/Share
|
|
Apr 02
2025
|
Jeremy B. Hayden Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
9,395
-3.3%
|
$18,790
$2.31 P/Share
|
|
Apr 02
2025
|
Alison Bauerlein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
19,397
-2.9%
|
$38,794
$2.31 P/Share
|
|
Apr 01
2025
|
David Badawi Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
5,980
-0.32%
|
$11,960
$2.3 P/Share
|
|
Apr 01
2025
|
Paul Badawi President and CEO |
SELL
Open market or private sale
|
Direct |
24,174
-0.4%
|
$48,348
$2.3 P/Share
|